Editorial Editorial Dear theriogenologists, You might have noticed that you have a new editor for our professional journal. Four decades of learning and growing experiences in theriogenology have prepared me for this important assignment. Have I arrived or perfected to know everything in theriogenology? No, and no one can; I am still learning. I am very thankful to the Task Force and the Executive Board of SFT to have chosen me as the editor of our professional journal. I am equally thankful to Dr. Charles Franz for his able leadership in the process of selecting a successor to the founding editor of Clinical Theriogenology, Dr. Bob Youngquist. Bob was a strong supporter during my Purdue academic career. Furthermore, I am grateful that I met all the seven ideal qualities that he wished to see in his successor. It is a privilege to follow his footsteps in editing. I am sure that we will recognize Bob at an appropriate time for serving all of us very well. I am aware of the responsibilities of this position and looking forward to serve with assistance from the talented members of the Editorial Board, Copy Editor Dr. John Kastelic (who has been a source of tremendous wisdom and strength, right from my graduate program/residency days at UW Madison), leadership and membership of SFT/ACT, Franz Management, and Omnipress. Moving forward, at the ripe time we plan to resubmit a Medline application for indexing. This task should only be attempted if our journal can address six important deficiencies noted by Medline. The first five issues are major; they pertain to the quality of our journal and depth of scholarship. In this regard, we have decided to approach colleagues to create reviews in their areas of expertise, keeping a focus on applied aspects of theriogenology, the reason why this journal was created. Please write to me (petera@purdue.edu), if you wish to contribute. We really need your support as we continue to build our journal! The final issue on the list is to have a few international members serving on the Editorial Board. I am reaching out to our international theriogenologists who have a track-record in scholarship. It is a three- year term and the major responsibility is to review 2 or 3 papers a year. Please let me know (petera@purdue.edu) if you have a desire to serve. Thanks. Augustine T. Peter 395 Clinical Theriogenology • Volume 10, Number 4 • December 2018